Перспективы терапевтического использования веществ из гриба Ganoderma lucidum
Реферат
В обзоре представлены данные литературы преимущественно за последние десять лет, касающиеся лечебно-профилактического действия веществ из гриба Ganoderma lucidum в отношении заболеваний терапевтического профиля. Описаны антидиабетические и антиатерогенные эффекты компонентов G. lucidum, охарактеризованы их гепато-, рено-, гастро- и церебропротективная, а также противоастматическая активность. Обсуждены перспективы терапевтического применения веществ из данного гриба.
Тэги
1. Baby S., Johnson A.J., Govindan B. Secondary metabolites from Ganoderma // Phytochemistry. 2015. 114. 66–101.
2. Bhowmick B., Singh D. Novel anti-inflammatory treatments for asthma // Expert Rev. Respir. Med. 2008. 2. (5). 617–629.
3. Braun M., Pietsch P., Schror K. et al. Cellular adhesion molecules on vascular smooth muscle cells // Cardiovasc. Res. 1999. 41. (2). 395–401.
4. Busse P.J., Schofield B., Birmingham N. et al. The traditional Chinese herbal formula ASHMI inhibits allergic lung inflammation in antigen-sensitized and antigen-challenged aged mice // Ann. Allergy Asthma Immunol. 2010. 104. (3). 236–246.
5. Gao Y., Lan J., Dai X. et al. A phase I/II study of Lingzhi mushroom Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with type II diabetes mellitus // Int. J. Med. Mushrooms. 2004. 6. 33–40.
6. Gao Y., Tang W., Gao H. et al. Ganoderma lucidum polysaccharide fractions accelerate healing of acetic acid-induced ulcers in rats // J. Med. Food. 2004. 7. (4). 417–421.
7. Gao Y., Zhou S., Wen J. et al. Mechanism of the antiulcerogenic effect of Ganoderma lucidum polysaccharides on indomethacin-induced lesions in the rat // Life Sci. 2002. 72. (6). 731–745.
8. Ha do T., Oh J., Khoi N.M. et al. In vitro and in vivo hepatoprotective effect of ganodermanontriol against t-BHP-induced oxidative stress // J. Ethnopharmacol. 2013. 150. (3). 875–885.
9. He C.Y., Li W.D., Guo S.X. et al. Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice // J. Asian Nat. Prod. Res. 2006. 8. (8). 705–711.
10. Jayaprakasam B., Yang N., Wen M.C. et al. Constituents of the anti-asthma herbal formula ASHMI(TM) synergistically inhibit IL-4 and IL-5 secretion bymurine Th2 memory cells, and eotaxin by human lung fibroblasts in vitro // J. Integr. Med. 2013. 11. (3). 195–205.
11. Kelly-Pieper K., Patil S.P., Busse P. et al. Safety and tolerability of an antiasthma herbal Formula (ASHMI) in adult subjects with asthma: a randomized, double-blinded, placebo-controlled, dose-escalation phase I study // J. Altern. Complement. Med. 2009. 15. (7). 735–743.
12. Kim D.H., Shim S.B., Kim N.J., Jang I.S. Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum // Biol. Pharm. Bull. 1999. 22. (2). 162–164.
13. Klupp N.L., Chang D., Hawke F. et al. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors // Cochrane Database Syst. Rev. 2015. 2. doi: 10.1002/14651858.CD007259.pub2.
14. Konturek P.C., Duda A., Brzozowski T. et al. Activation of genes for superoxide dismutase, interleukin-1beta, tumor necrosis factor-alpha, and intercellular adhesion molecule-1 during healing of ischemia-reperfusion-induced gastric injury // Scand. J. Gastroenterol. 2000. 35. (5). 452–463.
15. Lai K.N., Chan L.Y., Tang S.C., Leung J.C. Ganoderma extract prevents albumin-induced oxidative damage and chemokines synthesis in cultured humanproximal tubular epithelial cells // Nephrol. Dial. Transplant. 2006. 21. (5). 1188–1197.
16. Lakshmi B., Ajith T.A., Jose N., Janardhanan K.K. Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene // J. Ethnopharmacol. 2006. 107. (2). 297–303.
17. Lasukova T.V., Maslov L.N., Arbuzov A.G. et al. Cardioprotective activity of Ganoderma lucidum extract during total ischemia and reperfusion of isolated heart // Bull. Exp. Biol. Med. 2015. 158 (6). 739–741.
18. Li Y.Q., Wang S.F. Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum // Biotechnol. Lett. 2006. 28. (11). 837–841.
19. Lin C.Y., Chen Y.H., Lin C.Y. et al. Ganoderma lucidum polysaccharides attenuate endotoxin-induced intercellular cell adhesion molecule-1 expression in cultured smooth muscle cells and in the neointima in mice // J. Agric. Food Chem. 2010. 58. (17). 9563–9571.
20. Liu C., Yang N., Song Y. et al. Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-α production by mouse macrophages and peripheral blood mononuclear cells from asthma patients // Int. Immunopharmacol. 2015. 27. (2). 224–231.
21. Liu Y.J., Du J.L., Cao L.P. et al. Anti-inflammatory and hepatoprotective effects of Ganoderma lucidum polysaccharides on carbon tetrachloride-induced hepatocyte damage in common carp (Cyprinus carpio L.) // Immunopharmacol. 2015. 25. (1). 112–120.
22. Lu J., Sun L.X., Lin Z.B. et al. Antagonism by Ganoderma lucidum polysaccharides against the suppression by culture supernatants of B16F10 melanoma cells on macrophage // Phytother. Res. 2014. 28. (2). 200–206.
23. Ma H.T., Hsieh J.F., Chen S.T. Anti-diabetic effects of Ganoderma lucidum // Phytochemistry. 2015. 114. 109–113.
24. Min-Chang G., Wei-Hong T., Zhen X., Jie S. Effects of selenium-enriched protein from Ganoderma lucidum on the levels of IL-1 β and TNF-α, oxidative stress, and NF-κ B activation in ovalbumin-induced asthmatic mice // Evid. Based Complement. Alternat. Med. 2014. doi: 10.1155/2014/182817.
25. Misso N.L., Powers K.A., Gillon R.L. et al. Reduced platelet glutathione peroxidase activity and serum selenium concentration in atopic asthmatic patients // Clin. Exp. Allergy. 1996. 26. (7). 838–847.
26. Pan D., Zhang D., Wu J. et al. A novel proteoglycan from Ganoderma lucidum fruiting bodies protects kidney function and ameliorates diabetic nephropathy via its antioxidant activity in 57BL/6 db/db mice // Food Chem. Toxicol. 2014. 63. 111–118.
27. Pan D., Zhang D., Wu J. et al. Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from Ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism // PLoS One. 2013. 8. (7). e68332.
28. Park J.H., Jang K.J., Kim C.H. et al. Ganoderma lucidum pharmacopuncture for teating ethanol-induced chronic gastric ulcers in rats // J. Pharmacopuncture. 2015. 18. (1). 72–78.
29. Pillai T.G., John M., Sara T.G. Prevention of cisplatin induced nephrotoxicity by terpenes isolated from Ganoderma lucidum occurring in Southern Parts of India // Exp. Toxicol. Pathol. 2011. 63. (1-2). 157–160.
30. Shi Y., Sun J., He H. et al. Hepatoprotective effects of Ganoderma lucidum peptides against D-galactosamine-induced liver injury in mice // J. Ethnopharmacol. 2008. 117. (3). 415–419.
31. Shieh Y.H., Liu C.F., Huang Y.K. et al. Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice // Am. J. Chin. Med. 2001. 29. (3-4). 501–507.
32. Srivastava K., Sampson H.A., Emala C.W. Sr., Li X.M. The anti-asthma herbal medicine ASHMI acutely inhibits airway smooth muscle contraction via prostaglandin E2 activation of EP2/EP4 receptors // Am. J. Physiol. Lung Cell. Mol. Physiol. 2013. 305. doi: 10.1152/ajplung.00423.2012.
33. Suzuki T., Grand E., Bowman C. et al. TNF-alpha and interleukin 1 activate gastrin gene expression via MAPK- and PKC-dependent mechanisms // Am. J. Physiol. 2001. 281. (6). 1405–1412.
34. Tansey M.G. and Goldberg M.S. Neuroinflammation in Parkinson’s disease: its role in neuronal death and implications for therapeutic intervention // Neurobiol. Dis. 2010. 37. (3). 510–518.
35. Teng B.S., Wang C.D., Zhang D. et al. Hypoglycemic effect and mechanism of a proteoglycan from Ganoderma lucidum on streptozotocin-induced type 2 diabetic rats // Eur. Rev. Med. Pharmacol. Sci. 2012. 16. (2). 166–175.
36. Wallace J.L., Granger D.N. The cellular and molecular basis of gastric mucosal defense // FASEB J. 1996. 10. (7). 731–740.
37. Wang C.D., Teng B.S., He Y.M. et al. Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice // Br. J. Nutr. 2012. 108. (11). 2014–2025.
38. Wang F., Zhou Z., Ren X. et al. Effect of Ganoderma lucidum spores intervention on glucose and lipid metabolism gene expression profiles in type 2 diabetic rats // Lipids Health Dis. 2015. 14. doi: 10.1186/s12944-015-0045-y.
39. Wang P.Y., Zhu X.L., Lin Z.B. Antitumor and immunomodulatory effects of polysaccharides from broken-spore of Ganoderma lucidum // Front. Pharmacol. 2012. 3. doi: 10.3389/fphar.2012.00135.
40. Wang S.H., Liang C.J., Weng Y.W. et al. Ganoderma lucidum polysaccharides prevent platelet-derived growth factor-stimulated smooth muscle cell proliferation in vitro and neointimal hyperplasia in the endothelial-denuded artery in vivo // J. Cell Physiol. 2012. 227. (8). 3063–3071.
41. Wanmuang H., Leopairut J., Kositchaiwat C. et al. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder // J. Med. Assoc. Thai. 2007. 90. (1). 179–181.
42. Wen M.C., Wei C.H., Hu Z.Q. et al. Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma // J. Allergy Clin. Immunol. 2005. 116. (3). 517–524.
43. Wu Y.W., Fang H.L., Lin W.C. Post-treatment of Ganoderma lucidum reduced liver fibrosis induced by thioacetamide in mice // Phytother. Res. 2010. 24. (4). 494–499.
44. Yoon H.M., Jang K.J., Han M.S. et al. Ganoderma lucidum ethanol extract inhibits the inflammatory response by suppressing the NF-κB and toll-like receptor pathways in lipopolysaccharide-stimulated BV2 microglial cells // Exp. Ther. Med. 2013. 5. (3). 957–963.
45. Zhang R., Xu S., Cai Y. et al. Ganoderma lucidum protects dopaminergic neuron degeneration through inhibition of microglial activation // Evid. Based Complement. Alternat. Med. 2011. doi: 10.1093/ecam/nep075.
46. Zhang T., Srivastava K., Wen M.C. et al. Pharmacology and immunological actions of a herbal medicine ASHMI on allergic asthma // Phytother. Res. 2010. 24. (7). 1047–1055.
47. Zhang W., Zhang Q., Deng W. et al. Neuroprotective effect of pretreatment with Ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus // Neural. Regen. Res. 2014. 9. (15). 1446–1452.
48. Zheng J., Yang B., Yu Y. et al. Ganoderma lucidum polysaccharides exert anti-hyperglycemic effect on streptozotocin-induced diabetic rats through affecting β-cells // Comb. Chem. High Throughput Screen. 2012. 15. (7). 542–550.
49. Zhong D., Wang H., Liu M. et al. Ganoderma lucidum polysaccharide peptide prevents renal ischemia reperfusion injury via counteracting oxidative stress // Sci. Rep. 2015. 5. doi: 10.1038/srep16910.
Петрова Е.С. – к.т.н., научный сотрудник лаборатории молекулярно-клеточных механизмов терапевтических заболеваний, е-mail: ekamo9@yandex.ru
Долганова О.М. – к.м.н., научный сотрудник лаборатории молекулярно-клеточных механизмов терапевтических заболеваний, е-mail: kh_olgam@mail.ru
Шварц Я.Ш. – д.м.н., зав. лабораторией молекулярно-клеточных механизмов терапевтических заболеваний, е-mail: yshschwartz@mail.ru
